UBB_MOUSE - dbPTM
UBB_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UBB_MOUSE
UniProt AC P0CG49
Protein Name Polyubiquitin-B
Gene Name Ubb
Organism Mus musculus (Mouse).
Sequence Length 305
Subcellular Localization Cytoplasm. Nucleus.
Protein Description Ubiquitin: Exists either covalently attached to another protein, or free (unanchored). When covalently bound, it is conjugated to target proteins via an isopeptide bond either as a monomer (monoubiquitin), a polymer linked via different Lys residues of the ubiquitin (polyubiquitin chains) or a linear polymer linked via the initiator Met of the ubiquitin (linear polyubiquitin chains). Polyubiquitin chains, when attached to a target protein, have different functions depending on the Lys residue of the ubiquitin that is linked: Lys-6-linked may be involved in DNA repair; Lys-11-linked is involved in ERAD (endoplasmic reticulum-associated degradation) and in cell-cycle regulation; Lys-29-linked is involved in lysosomal degradation; Lys-33-linked is involved in kinase modification; Lys-48-linked is involved in protein degradation via the proteasome; Lys-63-linked is involved in endocytosis, DNA-damage responses as well as in signaling processes leading to activation of the transcription factor NF-kappa-B. Linear polymer chains formed via attachment by the initiator Met lead to cell signaling. Ubiquitin is usually conjugated to Lys residues of target proteins, however, in rare cases, conjugation to Cys or Ser residues has been observed. When polyubiquitin is free (unanchored-polyubiquitin), it also has distinct roles, such as in activation of protein kinases, and in signaling..
Protein Sequence MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Acetylation--MQIFVKTLTGKTI
--CEEEEEECCCCEE
27.37-
6Malonylation--MQIFVKTLTGKTI
--CEEEEEECCCCEE
27.3726320211
6Ubiquitination--MQIFVKTLTGKTI
--CEEEEEECCCCEE
27.37-
7Phosphorylation-MQIFVKTLTGKTIT
-CEEEEEECCCCEEE
25.0127600695
9PhosphorylationQIFVKTLTGKTITLE
EEEEEECCCCEEEEE
41.6926643407
11AcetylationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.3623236377
11MalonylationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.3626320211
11UbiquitinationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.36-
12PhosphorylationVKTLTGKTITLEVEP
EEECCCCEEEEEECC
22.1227180971
14PhosphorylationTLTGKTITLEVEPSD
ECCCCEEEEEECCCC
23.3027742792
20PhosphorylationITLEVEPSDTIENVK
EEEEECCCCHHHHHH
33.6026745281
22PhosphorylationLEVEPSDTIENVKAK
EEECCCCHHHHHHHH
34.2326745281
27AcetylationSDTIENVKAKIQDKE
CCHHHHHHHHHCCCC
56.3923806337
27SuccinylationSDTIENVKAKIQDKE
CCHHHHHHHHHCCCC
56.3923806337
27UbiquitinationSDTIENVKAKIQDKE
CCHHHHHHHHHCCCC
56.39-
29UbiquitinationTIENVKAKIQDKEGI
HHHHHHHHHCCCCCC
34.87-
33AcetylationVKAKIQDKEGIPPDQ
HHHHHCCCCCCCHHH
41.2723806337
33UbiquitinationVKAKIQDKEGIPPDQ
HHHHHCCCCCCCHHH
41.27-
48AcetylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.5623864654
48MalonylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.5626320211
48SuccinylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.5623806337
48UbiquitinationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.56-
55PhosphorylationKQLEDGRTLSDYNIQ
EECCCCCCCCCCCCC
35.8224925903
57PhosphorylationLEDGRTLSDYNIQKE
CCCCCCCCCCCCCCH
37.1224925903
59PhosphorylationDGRTLSDYNIQKEST
CCCCCCCCCCCCHHE
15.7024925903
63AcetylationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.2423236377
63MalonylationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.2426320211
63UbiquitinationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.24-
65PhosphorylationDYNIQKESTLHLVLR
CCCCCCHHEEEEEEE
43.2227742792
66PhosphorylationYNIQKESTLHLVLRL
CCCCCHHEEEEEEEE
21.2022324799
76ADP-ribosylationLVLRLRGGMQIFVKT
EEEEECCCEEEEEEE
9.82-
82AcetylationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.37-
82MalonylationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.3726320211
82UbiquitinationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.37-
83PhosphorylationGMQIFVKTLTGKTIT
CEEEEEEECCCCEEE
25.0127600695
85PhosphorylationQIFVKTLTGKTITLE
EEEEEECCCCEEEEE
41.6926643407
87MalonylationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.3626320211
87UbiquitinationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.36-
88PhosphorylationVKTLTGKTITLEVEP
EEECCCCEEEEEECC
22.1227180971
90PhosphorylationTLTGKTITLEVEPSD
ECCCCEEEEEECCCC
23.3027742792
96PhosphorylationITLEVEPSDTIENVK
EEEEECCCCHHHHHH
33.6026745281
98PhosphorylationLEVEPSDTIENVKAK
EEECCCCHHHHHHHH
34.2326745281
103UbiquitinationSDTIENVKAKIQDKE
CCHHHHHHHHHCCCC
56.39-
105UbiquitinationTIENVKAKIQDKEGI
HHHHHHHHHCCCCCC
34.87-
109AcetylationVKAKIQDKEGIPPDQ
HHHHHCCCCCCCHHH
41.27-
109UbiquitinationVKAKIQDKEGIPPDQ
HHHHHCCCCCCCHHH
41.27-
124AcetylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.56-
124MalonylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.5626320211
124UbiquitinationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.56-
131PhosphorylationKQLEDGRTLSDYNIQ
EECCCCCCCCCCCCC
35.8224925903
133PhosphorylationLEDGRTLSDYNIQKE
CCCCCCCCCCCCCCH
37.1224925903
135PhosphorylationDGRTLSDYNIQKEST
CCCCCCCCCCCCHHE
15.7024925903
139AcetylationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.24-
139MalonylationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.2426320211
139UbiquitinationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.24-
141PhosphorylationDYNIQKESTLHLVLR
CCCCCCHHEEEEEEE
43.2227742792
142PhosphorylationYNIQKESTLHLVLRL
CCCCCHHEEEEEEEE
21.2022324799
158AcetylationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.37-
158MalonylationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.3726320211
158UbiquitinationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.37-
159PhosphorylationGMQIFVKTLTGKTIT
CEEEEEEECCCCEEE
25.0127600695
161PhosphorylationQIFVKTLTGKTITLE
EEEEEECCCCEEEEE
41.6926643407
163MalonylationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.3626320211
163UbiquitinationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.36-
164PhosphorylationVKTLTGKTITLEVEP
EEECCCCEEEEEECC
22.1227180971
166PhosphorylationTLTGKTITLEVEPSD
ECCCCEEEEEECCCC
23.3027742792
172PhosphorylationITLEVEPSDTIENVK
EEEEECCCCHHHHHH
33.6026745281
174PhosphorylationLEVEPSDTIENVKAK
EEECCCCHHHHHHHH
34.2326745281
179UbiquitinationSDTIENVKAKIQDKE
CCHHHHHHHHHCCCC
56.39-
181UbiquitinationTIENVKAKIQDKEGI
HHHHHHHHHCCCCCC
34.87-
185AcetylationVKAKIQDKEGIPPDQ
HHHHHCCCCCCCHHH
41.27-
185UbiquitinationVKAKIQDKEGIPPDQ
HHHHHCCCCCCCHHH
41.27-
200AcetylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.56-
200MalonylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.5626320211
200UbiquitinationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.56-
207PhosphorylationKQLEDGRTLSDYNIQ
EECCCCCCCCCCCCC
35.8224925903
209PhosphorylationLEDGRTLSDYNIQKE
CCCCCCCCCCCCCCH
37.1224925903
211PhosphorylationDGRTLSDYNIQKEST
CCCCCCCCCCCCHHE
15.7024925903
215AcetylationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.24-
215MalonylationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.2426320211
215UbiquitinationLSDYNIQKESTLHLV
CCCCCCCCHHEEEEE
50.24-
217PhosphorylationDYNIQKESTLHLVLR
CCCCCCHHEEEEEEE
43.2227742792
218PhosphorylationYNIQKESTLHLVLRL
CCCCCHHEEEEEEEE
21.2022324799
234AcetylationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.37-
234MalonylationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.3726320211
234UbiquitinationGGMQIFVKTLTGKTI
CCEEEEEEECCCCEE
27.37-
235PhosphorylationGMQIFVKTLTGKTIT
CEEEEEEECCCCEEE
25.0127600695
237PhosphorylationQIFVKTLTGKTITLE
EEEEEECCCCEEEEE
41.6926643407
239MalonylationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.3626320211
239UbiquitinationFVKTLTGKTITLEVE
EEEECCCCEEEEEEC
31.36-
240PhosphorylationVKTLTGKTITLEVEP
EEECCCCEEEEEECC
22.1227180971
242PhosphorylationTLTGKTITLEVEPSD
ECCCCEEEEEECCCC
23.3027742792
248PhosphorylationITLEVEPSDTIENVK
EEEEECCCCHHHHHH
33.6026745281
250PhosphorylationLEVEPSDTIENVKAK
EEECCCCHHHHHHHH
34.2326745281
255UbiquitinationSDTIENVKAKIQDKE
CCHHHHHHHHHCCCC
56.39-
257UbiquitinationTIENVKAKIQDKEGI
HHHHHHHHHCCCCCC
34.87-
261AcetylationVKAKIQDKEGIPPDQ
HHHHHCCCCCCCHHH
41.27-
261UbiquitinationVKAKIQDKEGIPPDQ
HHHHHCCCCCCCHHH
41.27-
276AcetylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.56-
276MalonylationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.5626320211
276UbiquitinationQRLIFAGKQLEDGRT
HEEEEEEEECCCCCC
48.56-
283PhosphorylationKQLEDGRTLSDYNIQ
EECCCCCCCCCCCCC
35.8224925903
285PhosphorylationLEDGRTLSDYNIQKE
CCCCCCCCCCCCCCH
37.1224925903
287PhosphorylationDGRTLSDYNIQKEST
CCCCCCCCCCCCHHE
15.7024925903
291AcetylationLSDYNIQKESTLHLV
CCCCCCCCHHEEEHH
50.24-
291MalonylationLSDYNIQKESTLHLV
CCCCCCCCHHEEEHH
50.2426320211
291UbiquitinationLSDYNIQKESTLHLV
CCCCCCCCHHEEEHH
50.24-
293O-linked_GlycosylationDYNIQKESTLHLVLR
CCCCCCHHEEEHHHE
43.2222645316
293PhosphorylationDYNIQKESTLHLVLR
CCCCCCHHEEEHHHE
43.2227180971
294PhosphorylationYNIQKESTLHLVLRL
CCCCCHHEEEHHHEE
21.2022324799

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
65SPhosphorylationKinasePINK1Q99MQ3
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
65SPhosphorylation

-
65Subiquitylation

-

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UBB_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
POLK_MOUSEPolkphysical
18162470

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UBB_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale phosphorylation analysis of mouse liver.";
Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57, AND MASSSPECTROMETRY.

TOP